COMMUNIQUÉS West-GlobeNewswire

Capital Increase in Genmab as a Result of Employee Warrant Exercise
12/05/2026
Company Announcement COPENHAGEN, Denmark; May 12, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 2,346 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
12/05/2026
CBeyond™ Expansion Study (Part C) initiated; Cohort Review Committee review scheduled for May 18, 2026, to evaluate available safety data and potential progression to Cohort 2 SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE [...]
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
12/05/2026
Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis (3) at constant exchange rates (CER); adverse FX impact of € 29.1 million (-4.3%) EBITDA (1) of € 283.6 [...]
To Your Health Launches Innovative Online Protein Intake Calculator
12/05/2026
New Science-Based Tool Aims to Prevent Muscle Loss and Maintain Bone Density in Middle-Aged Women and Aging Adults Wallingford, CT, May 12, 2026 (GLOBE NEWSWIRE) -- TO YOUR HEALTH, a leader in personalized nutrition and [...]
ATUM’s New Lock-In Platform Solves Bispecific Mispairing
12/05/2026
The Platform Addresses a Key Bottleneck in Multispecific Antibody Engineering NEWARK, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- ATUM, a global leader in bioengineering and cell line development, today announced the [...]
Rosewood STEM Magnet’s Year of National Honors Draws Recognition from McComb Orthodontics West Hollywood
12/05/2026
Ryan McComb of McComb Orthodontics West Hollywood with Friends of Rosewood STEM Elementary Board Member Katie Pisciotta, Co-President Jasmin Patterson, Board Member Ava Surkes, Co-President Anne Ramallo, Board Member [...]
High Diet Surpasses 1,700 Customer Reviews as Users Praise Personalized High-Protein Meal Plans
12/05/2026
1,700+ customer reviews point to High Diet's personalized high-protein meal plans and fitness tracking as the features keeping users coming back NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- High Diet has launched a [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
12/05/2026
Bagsværd, Denmark, 12 May 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with [...]
Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition
12/05/2026
– Abstracts highlight strong revumenib activity across the acute leukemia treatment continuum and multiple genetic subtypes – – New real-world data show compelling outcomes and favorable tolerability with revumenib [...]
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
12/05/2026
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day LANGHORNE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, [...]
Extendicare Files Business Acquisition Report in connection with the CBI Home Health Acquisition
12/05/2026
MARKHAM, Ontario, May 12, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) has filed a Business Acquisition Report on Form 51-102F4 (the “BAR”) on SEDAR+ ( www.sedarplus.ca ) in [...]
LiveWorld's New APP Research Council Gives Brands Direct Access to Frontline NP and PA Insights to Improve Relevance, Reach, and ROI
12/05/2026
Targets a long-overlooked gap in pharma marketing: the APP audience driving half of prescribing decisions CAMPBELL, Calif. and NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), a leader in [...]
Mental Health Awareness Month: TPN.health Solves the Access Crisis Costing Self-Insured Stakeholders, Health Plans and Members the Care They Deserve
12/05/2026
NEW ORLEANS, May 12, 2026 (GLOBE NEWSWIRE) -- TPN.health , the operating system for behavioral health, is redefining what access to mental health care means for self-funded employers, health plans and the millions of [...]
Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List
12/05/2026
DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Becker’s Hospital Review has named Leap Distributors Co-founder and CEO Allen Mason to the 2026 list of Great Leaders in Healthcare. Mason is included in the Companies section, [...]
Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
12/05/2026
– Oral presentation to feature 99-patient dataset with extended follow-up in newly diagnosed NPM1-m or KMT2A-r AML – – High CRc rates (90–96%) with deep MRD negativity (> 80%) across both subtypes – – Durable [...]
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
12/05/2026
WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives [...]
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
12/05/2026
Investigator-sponsored study, conducted at the Moffitt Cancer Center, demonstrates safety and efficacy consistent with the Phase 3 IMerge trial in a broader patient population Additional presentations at EHA 2026 and [...]
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
12/05/2026
sNDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathway Confirmatory trial designed to demonstrate clinical benefit of mitapivat on reducing transfusion burden [...]
BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026
12/05/2026
Treatment with BH-30236, a novel CLK inhibitor, was generally well tolerated as monotherapy and in combination with venetoclax Preliminary anti-leukemic activity observed, including patients that were previously treated [...]

Pages